3 New Strong Buy Ratings from Top-Rated Analysts: 10/27/2026
Oh, lucky you. We’ve sourced 3 high-potential picks with big upside potential and strong fundamentals:
- Electromed (ELMD): Analysts maintain 50%+ upside targets
- Omnicell Inc (OMCL): This top-rated stock in its industry is getting fresh upgrades
- TTM Technologies (TTMI): 2 top-rated analysts see over 100% upside
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
The ONLY AI opportunity you should be looking at
This is the ONLY AI wealth-building opportunity you should be watching right now.
No. It's not about Nvidia, Tesla, or Meta...
It's about one overlooked company profiting off AI "digital goldmines" that are poised to experience 100x growth very soon.
This new opportunity will change the market and make investors a lot of money.
That's why it has received a $500 billion commitment from President Trump himself...
Learn more about this little-known company here >>>
1. Electromed (NYSEMKT: ELMD)
Electromed develops, manufactures, and markets medical equipment for airway clearance therapy, with its flagship SmartVest system addressing the underserved bronchiectasis market. The company is positioned for sustained double-digit growth, supported by expanding payer coverage and a large underpenetrated patient population.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $26.37 — get current quote
Max 1-year forecast: $47.00
Why we're watching:
- ELMD has limited, but overall bullish, coverage among the analysts we track, with 2 Strong Buy recommendations. See all recommendations here
- For example, B. Riley Securities researcher Kyle Bauser (a top 21% rated analyst) maintains his Strong Buy recommendation with a price target that suggests the stock could see upside potential from current levels.
- Q3 earnings demonstrated execution strength: EPS of $0.35 beat estimates by 34.62% with 66.67% year-over-year growth, while revenue of $18.58M exceeded expectations by 4.35% with 19.89% YoY growth.
- Industry ranking context: ELMD is currently the #4 highest-rated stock in the Medical Device industry, which has an Industry Rating of C.
- Zen Ratings highlights: ELMD earns an overall A rating, which amounts to a Strong Buy recommendation. Stocks with this rating represent the elite top 5% of all stocks tracked based on a rigorous 115-factor fundamental review.
- Component Grades: ELMD excels for Financials with an A grade, reflecting the company's strong profit margin and robust balance sheet, while maintaining solid Bs for Sentiment and Value, a combination that supports continued appreciation in this high-growth medical device segment. See all 7 Component Grades here
2. Omnicell (NASDAQ: OMCL)
Omnicell provides healthcare technology solutions that automate and improve medication management and supply chain operations for hospitals and pharmacies across the U.S. and internationally. The company's expanding customer base and sustainable competitive advantages position it well for the ongoing automation trend in healthcare.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $37.75 — get current quote
Max 1-year forecast: $65.00
Why we're watching:
- OMCL has solid, bullish coverage among the analysts we track, with 3 Strong Buy recommendations. See all recommendations here
- For example, Piper Sandler researcher Jessica Tassan (a top 30% rated analyst) recently reiterated her Strong Buy recommendation with a price target representing about 20% upside potential from current levels.
- Better still, Wells Fargo researcher Stan Berenshteyn (a top 22% rated analyst) maintained his Strong Buy with a price target representing over 30% upside potential from current levels.
- Industry ranking context: OMCL is currently the #1 highest-rated stock in the Health Information Service industry, which has an Industry Rating of B.
- Zen Ratings highlights: OMCL earns an overall A rating, which is equal to a Strong Buy recommendation. Stocks in this topmost tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
- Component Grades: OMCL demonstrates balanced strength with strong Bs for Growth, Safety, Sentiment, and Value, reflecting the company's stable operational performance and favorable positioning in the healthcare automation market. See all 7 Component Grades here
3. TTM Technologies (NASDAQ: TTMI)
TTM Technologies specializes in the production and distribution of printed circuit boards (PCBs) through two key operating segments, serving critical technology infrastructure needs. The company is experiencing exceptional growth momentum driven by strong demand across its product portfolio and strategic market positioning.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $80.11 — get current quote
Max 1-year forecast: $208.00
Why we're watching:
- TTMI has strong, bullish coverage among the analysts we track, with 3 Strong Buy and 1 Buy recommendations. See all recommendations here
- For example, Stifel Nicolaus researcher Ruben Roy (a top 1% rated analyst) maintained his Strong Buy with a price target representing 105% upside potential from current levels.
- Likewise, Truist Securities researcher William Stein (a top 1% rated analyst) recently maintained his Strong Buy rating with a price target representing greater than 110% upside potential from current levels.
- Q3 earnings demonstrated robust execution: EPS of $4.92 beat estimates by 7.64% with 75.91% year-over-year growth, while revenue of $4.5B exceeded expectations by 33.07% with 30.73% YoY growth.
- Industry ranking context: TTMI is currently the #2 highest-rated stock in the Electronic Component industry, which has an Industry Rating of A.
- Zen Ratings highlights: TTMI earns an overall A rating, which equals a Strong Buy recommendation. This tier represents stocks that have passed a rigorous 115-factor fundamental review and historically delivered market-beating returns.
- Component Grades: TTMI shines with an A for Growth, reflecting exceptional revenue and earnings expansion, while maintaining solid Bs for Financials and Sentiment, positioning the company well for continued outperformance in the expanding PCB market. See all 7 Component Grades here
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.